February 16, 2018
Rose
Insulin dose tool gains CE Mark. DreaMed Diabetes has received a CE Mark for its Type 1-focused clinical decision support (CDS) platform, Advisor Pro. The tool’s algorithms process data from a number of connected diabetes management devices to provide a personalized insulin dosing treatment plan.
from MobiHealthNews http://ift.tt/2C1C5eT
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment